Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
8.58
-0.32 (-3.60%)
Mar 2, 2026, 4:00 PM EST - Market closed
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $58.19 million as of March 3, 2026. Its market cap has decreased by -62.61% in one year.
Market Cap
58.19M
Enterprise Value
63.44M
1-Year Change
-62.61%
Ranking
Category
Stock Price
$8.58
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $58.19M, a decrease of -97.69%. That is a compound annual growth rate of -53.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 58.19M | -22.00% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | 2.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 63.74M |
| Q32 Bio | 63.71M |
| InflaRx | 62.33M |
| Alterity Therapeutics | 61.98M |
| TScan Therapeutics | 60.15M |
| ImmuCell | 59.43M |
| NRx Pharmaceuticals | 59.28M |
| Mereo BioPharma Group | 58.97M |